Invitation to the QbD/PAT Conference

The event has already taken place.

More details about the next conference will be published here as soon as available.

Please click here to find the current ECA Training Courses and Conferences.

Dear Sir or Madam,

After 9 successful Conferences from 2005 to 2013 which tracked the evolution of PAT and QbD, we would like to invite you to participate in

The University of Heidelberg International QbD / PAT Conference 2014.

Once again, this year’s event will provide a broad ranging platform for informative and interactive discussions with contributions by recognised experts from industry and regulatory authorities.

This year’s programme will review the pivotal role PAT plays in delivering the levels of process understanding and process control necessary to replace conventional approaches to validation with continuous verification over the product lifecycle enabling further rapid adoption of Real Time Release (RTR) in pharmaceutical batch and continuous manufacturing.

Practical applications will be presented and potential hurdles discussed relating to technical approaches to drug product development, manufacture and regulatory expectations.

In addition, the opportunities and challenges critical to continuous processing will be addressed.

The conference offers a broad range of highly interactive sessions with case studies and lectures where experts will share their knowledge and experiences in the following areas:

  • Regulation
  • PAT
  • QbD
  • R&D
  • Manufacturing
  • Small Molecules and Large Molecules
  • Life Cycle Management
It would be a great pleasure for me to welcome you in Heidelberg on behalf of the Institute of Pharmacy and Molecular Biotechnology.

Dr Gabriele Reich
IPMB, University of Heidelberg


Dr Gabriele Reich
Faculty of Biological Sciences, University of Heidelberg

Sander van den Ban

GSK, Hertfordshire, UK

Dr Oyvind Holte
Norwegian Medicines Agency

Fiona Clarke
Pfizer Ltd., Sandwich, Kent, UK

Dr Ajaz Hussain
Insight, Advice & Solutions, LLC, USA

Dr Peter McDonnell
Sanofi, Paris, France

Karthik Iyer
(via video conference)


Dr Peter Poechlauer

Justin Pritchard
Vertex, USA